Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.40 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.37 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.37 |
| ▸ | RELA | Q04206 | 1/20 | 0.37 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.34 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | KIF11 | P52732 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.33 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31256061 | 1.00 | CYP19A1 (0.42) | CYP19A1KDM4EHSP90AA1SMN1; SMN2NPC1 | |
| SCHEMBL4630149 | 0.80 | CYP19A1 (0.40) | CYP19A1KDM4EHSP90AA1SMN1; SMN2NPC1 | |
| SCHEMBL20774860 | 0.80 | CYP19A1 (0.40) | CYP19A1KDM4EHSP90AA1SMN1; SMN2NPC1 | |
| SCHEMBL9474833 | 0.80 | CYP19A1 (0.48) | CYP19A1KDM4EHSP90AA1SMN1; SMN2NPC1 | |
| SCHEMBL19573760 | 0.80 | HSP90AA1 (0.42) | CYP19A1KDM4EHSP90AA1SMN1; SMN2NPC1 | |
| SCHEMBL9589700 | 0.80 | CYP19A1 (0.40) | CYP19A1KDM4EHSP90AA1SMN1; SMN2NPC1 | |
| SCHEMBL8289716 | 0.80 | CYP19A1 (0.40) | CYP19A1KDM4EHSP90AA1SMN1; SMN2NPC1 | |
| SCHEMBL85681 | 0.80 | CYP19A1 (0.40) | CYP19A1KDM4EHSP90AA1SMN1; SMN2NPC1 | |
| SCHEMBL20128883 | 0.80 | CYP19A1 (0.40) | CYP19A1KDM4EHSP90AA1SMN1; SMN2NPC1 | |
| SCHEMBL28453438 | 0.80 | CYP19A1 (0.44) | CYP19A1KDM4EHSP90AA1SMN1; SMN2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1963 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260096585-A1 | ORAL COMPOSITION | KAO CORPORATION (JP) | 2026-04-09 | — | — | US | claimed |
| EP-4591720-A1 | ORAL COMPOSITION | Kao Corporation (JP) | 2025-07-30 | — | — | EP | claimed |
| US-20250177275-A1 | ACTIVE AGENT MODULATING THE ACTIVITY OF AN ION CHANNEL FOR USE IN INHIBITION OF SKIN AGING | CUTANEON - SKIN & HAIR INNOVATIONS GMBH (DE) | 2025-06-05 | — | — | US | claimed |
| US-20250143995-A1 | ACTIVE AGENT MODULATING THE ACTIVITY OF AN ION CHANNEL FOR USE IN REGULATION OF SKIN PIGMENTATION | CUTANEON - SKIN & HAIR INNOVATIONS GMBH (DE) | 2025-05-08 | — | — | US | claimed |
| WO-2024063038-A1 | ORAL COMPOSITION | 花王株式会社 | 2024-03-28 | — | — | WO | claimed |
| US-20230321122-A1 | ACTIVE AGENT MODULATING THE ACTIVITY OF AN ION CHANNEL FOR USE IN HAIR GROWTH REGULATION | CUTANEON SKIN & HAIR INNOVATIONS GMBH (DE) | 2023-10-12 | — | — | US | claimed |
| WO-2023161050-A1 | ACTIVE AGENT MODULATING THE ACTIVITY OF AN ION CHANNEL FOR USE IN INHIBITION OF SKIN AGING | CUTANEON - SKIN & HAIR INNOVATIONS GMBH (DE) | 2023-08-31 | — | — | WO | claimed |
| EP-4233833-A1 | ACTIVE AGENT MODULATING THE ACTIVITY OF AN ION CHANNEL FOR USE IN INHIBITION OF SKIN AGING | CUTANEON - Skin & Hair Innovations GmbH (DE) | 2023-08-30 | — | — | EP | claimed |
| WO-2023151931-A1 | ACTIVE AGENT MODULATING THE ACTIVITY OF AN ION CHANNEL FOR USE IN REGULATION OF SKIN PIGMENTATION | CUTANEON - SKIN & HAIR INNOVATIONS GMBH (DE) | 2023-08-17 | — | — | WO | claimed |
| EP-4226911-A1 | ACTIVE AGENT MODULATING THE ACTIVITY OF AN ION CHANNEL FOR USE IN REGULATION OF SKIN PIGMENTATION | CUTANEON - Skin & Hair Innovations GmbH (DE) | 2023-08-16 | — | — | EP | claimed |
| US-20140179722-A1 | Antiperspirant and Deodorant Compositions | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-26 | — | — | US | claimed |
| US-20140170194-A1 | FRAGRANCE MATERIALS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | US | claimed |
| WO-2014093807-A1 | FRAGRANCE MATERIALS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | WO | claimed |
| US-20140170101-A1 | Antiperspirant and Deodorant Compositions | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | US | claimed |
| CN-103497163-A | Synthesis method of dimethyl isobutyl pyrazine | PUCHENG YONGFANG FRAGRANCE TECHNOLOGY CO LTD | 2014-01-08 | — | — | CN | claimed |
| US-7820219-B2 | Toasted flavor additive | FRITO-LAY NORTH AMERICA, INC. (US) | 2010-10-26 | — | — | US | claimed |
| US-7364766-B2 | Toasted flavor additive and method of making | FRITO-LAY NORTH AMERICA, INC. (US) | 2008-04-29 | — | — | US | claimed |
| US-20080032022-A1 | Toasted Flavor Additive | FRITO-LAY NORTH AMERICA, INC. | 2008-02-07 | — | — | US | claimed |
| WO-2005039297-A1 | TOASTED FLAVOR ADDITIVE | FRITO-LAY NORTH AMERICA, INC. (US) | 2005-05-06 | — | — | WO | claimed |
| US-20050079269-A1 | made by cooking whole corn kernels in a solution of lime and water | FRITO-LAY NORTH AMERICA, INC. | 2005-04-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140170101-A1 | Antiperspirant and Deodorant Compositions | LPO, GPX4, DEK | CYP19A1 1807/4885KDM4E 1936/4885HSP90AA1 1846/4885 |
| US-20260096585-A1 | ORAL COMPOSITION | TAS2R5, TAS2R16, TAS2R45 | CYP19A1 3716/4885KDM4E 674/4885HSP90AA1 3944/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.